Phytol Down-Regulates Expression of Some Cancer Stem Cell Markers and Decreases Side Population Proportion in Human Embryonic Carcinoma NCCIT Cells

References

• Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med. 2007;58:267–84. doi:10.1146/annurev.med.58.062105.204854
   PubMed Web of Science ®Google Scholar
• Liu A, Yu X, Liu S. Pluripotency transcription factors and cancer stem cells: small genes make a big difference. Chin J Cancer. 2013;32(9):483–7. doi:10.5732/cjc.012.10282
   PubMedGoogle Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730–7. doi:10.1038/nm0797-730
   PubMed Web of Science ®Google Scholar
• Schatton T, Frank MH. Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res. 2008;21(1):39–55. doi:10.1111/j.1755-148X.2007.00427.x
   PubMed Web of Science ®Google Scholar
• Thomas M, Coyle K, Sultan M, Vaghar-Kashani A, Marcato P. Chemoresistance in cancer stem cells and strategies to overcome resistance. Chemotherapy. 2014;3(125):2.
   Google Scholar
• Abdullah LN, Chow E-H. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med. 2013;2(1):3doi:10.1186/2001-1326-2-3
   PubMedGoogle Scholar
• Shimoda M, Ota M, Okada Y. Isolation of cancer stem cells by side population method. In: Papaccio G, Desiderio V, editors. Cancer stem cells. Berlin (Germany): Springer; 2018. p. 49–59.
   Google Scholar
• Greve B, Kelsch R, Spaniol K, Eich HT, Götte M. Flow cytometry in cancer stem cell analysis and separation. Cytometry A. 2012;81(4):284–93. doi:10.1002/cyto.a.22022
   PubMedGoogle Scholar
• Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol. 2019;234(6):8381–95. doi:10.1002/jcp.27740
   PubMed Web of Science ®Google Scholar
• Chen K, Huang Y-h, Chen J-l. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin. 2013;34(6):732–40. doi:10.1038/aps.2013.27
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75(3):311–35. doi:10.1021/np200906s
   PubMed Web of Science ®Google Scholar
• Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, Capaccioli S. Natural compounds for cancer treatment and prevention. Pharmacol Res. 2009;59(6):365–78. doi:10.1016/j.phrs.2009.01.017
   PubMed Web of Science ®Google Scholar
• Amin A, Gali-Muhtasib H, Ocker M, Schneider-Stock R. Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci. 2009;5(1):1–11.
   PubMedGoogle Scholar
• Soltanian S, Mohamadi N, Rajaei P, Khodami M, Mohammadi M. Phytochemical composition, and cytotoxic, antioxidant, and antibacterial activity of the essential oil and methanol extract of Semenovia suffruticosa. Avicenna J Phytomed. 2019;9(2):143–52.
   PubMed Web of Science ®Google Scholar
• Soltanian S, Sheikhbahaei M, Mohamadi N. Cytotoxicity Evaluation of Methanol Extracts of Some Medicinal Plants on P19 Embryonal Carcinoma Cells. J App Pharm Sci. 2017;7(07):142–9. doi:10.7324/JAPS.2017.70722
   Google Scholar
• Soltanian S, Riahirad H, Pabarja A, Jafari E, Khandani BK. Effect of Cinnamic acid and FOLFOX in diminishing side population and downregulating cancer stem cell markers in colon cancer cell line HT-29. DARU J Pharm Sci. 2018;26(1):19–29. doi:10.1007/s40199-018-0210-8
   Web of Science ®Google Scholar
• Soltanian S, Riahirad H, Pabarja A, Karimzadeh MR, Saeidi K. Kaempferol and docetaxel diminish side population and down-regulate some cancer stem cell markers in breast cancer cell line MCF-7. Biocell. 2018;41(2):33–40. doi:10.32604/biocell.2017.00033
   Web of Science ®Google Scholar
• Taylor WF, Jabbarzadeh E. The use of natural products to target cancer stem cells. Am J Cancer Res. 2017;7(7):1588–605.
   PubMed Web of Science ®Google Scholar
• Breitmaier B. Terpenes: flavors, fragrances, pharmaca, pheromones. Hoboken (NJ): John Wiley & Sons; 2006.
   Google Scholar
• Davis EM, Croteau R. Cyclization enzymes in the biosynthesis of monoterpenes, sesquiterpenes, and diterpenes. In: Leeper FJ, Vederas JC, editors. Biosynthesis. Berlin (Germany): Springer; 2000. p. 53–95.
   Google Scholar
• Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments. Blood. 1990;76(9):1704–9. ].
   PubMed Web of Science ®Google Scholar
• Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G, et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res. 2010;16(10):2715–28.: doi:10.1158/1078-0432.CCR-09-1800
   PubMed Web of Science ®Google Scholar
• Yan Y, Li Z, Xu X, Chen C, Wei W, Fan M, Chen X, Li JJ, Wang Y, Huang J, et al. All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy. BMC Complement Altern Med. 2016;16(1):113: doi:10.1186/s12906-016-1088-y
   PubMedGoogle Scholar
• Ohno R, Asou N, Ohnishi K. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia. 2003;17(8):1454–63. doi:10.1038/sj.leu.2403031
   PubMed Web of Science ®Google Scholar
• Ginestier C, Wicinski J, Cervera N, Monville F, Finetti P, Bertucci F, Wicha MS, Birnbaum D, Charafe-Jauffret E. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle. 2009;8(20):3297–302. doi:10.4161/cc.8.20.9761
   PubMed Web of Science ®Google Scholar
• Ponthan F, BorgströM P, Hassan M, Wassberg E, Redfern CPF, Kogner P. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo. Med Pediatr Oncol. 2001;36(1):127–31. doi:10.1002/1096-911X(20010101)36:1<127::AID-MPO1030>3.0.CO;2-B
   PubMedGoogle Scholar
• Verhoeven NM, Wanders RJA, Poll-The BT, Saudubray J-M, Jakobs C. The metabolism of phytanic acid and pristanic acid in man: a review. J Inherited Metab Disease. 1998;21(7):697–728. doi:10.1023/A:1005476631419
   PubMed Web of Science ®Google Scholar
• Komiya T, Kyohkon M, Ohwaki S, Eto J, Katsuzaki H, Imai K, Kataoka T, Yoshioka K, Ishii Y, Hibasami H. Phytol induces programmed cell death in human lymphoid leukemia Molt 4B cells. Int J Mol Med. 1999;4(4):377–457. doi:10.3892/ijmm.4.4.377
   PubMed Web of Science ®Google Scholar
• Kim C-W, Lee HJ, Jung JH, Kim YH, Jung D-B, Sohn EJ, Lee JH, Woo HJ, Baek N-I, Kim YC, et al. Activation of Caspase-9/3 and Inhibition of Epithelial Mesenchymal Transition are Critically Involved in Antitumor Effect of Phytol in Hepatocellular Carcinoma Cells. Phytother Res. 2015;29(7):1026–31. doi:10.1002/ptr.5342
   PubMed Web of Science ®Google Scholar
• Thakor P, Subramanian RB, Thakkar SS, Ray A, Thakkar VR. Phytol induces ROS mediated apoptosis by induction of caspase 9 and 3 through activation of TRAIL, FAS and TNF receptors and inhibits tumor progression factor Glucose 6 phosphate dehydrogenase in lung carcinoma cell line (A549). Biomed Pharmacother. 2017;92:491–500. doi:10.1016/j.biopha.2017.05.066
   PubMed Web of Science ®Google Scholar
• Sheeja L, Lakshmi D, Bharadwaj S, Parveen KS. Anticancer activity of phytol purified from Gracilaria edulis against human breast cancer cell line (MCF-7). Int J Curr Sci. 2016;19(4):36–46.
   Google Scholar
• Radonić A, Blažević I, Mastelić J, Zekić M, Skočibušić M, Maravić A. Phytochemical analysis and antimicrobial activity of Cardaria draba (L.) Desv. volatiles. Chem Biodivers. 2011;8(6):1170–81. doi:10.1002/cbdv.201000370
   PubMed Web of Science ®Google Scholar
• Silva RO, Sousa FBM, Damasceno SRB, Carvalho NS, Silva VG, Oliveira FRMA, Sousa DP, Aragão KS, Barbosa ALR, Freitas RM, et al. Phytol, a diterpene alcohol, inhibits the inflammatory response by reducing cytokine production and oxidative stress. Fundam Clin Pharmacol. 2014;28(4):455–64.: doi:10.1111/fcp.12049
   PubMed Web of Science ®Google Scholar
• Teshima S, Shimosato Y, Hirohashi S, Tome Y, Hayashi I, Kanazawa H, Kakizoe T. Four new human germ cell tumor cell lines. Lab Invest. 1988;59(3):328–36.
   PubMed Web of Science ®Google Scholar
• Andrews PW. From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond, B, Biol Sci. 2002;357(1420):405–17. doi:10.1098/rstb.2002.1058
   PubMed Web of Science ®Google Scholar
• Martin GR. Teratocarcinomas and mammalian embryogenesis. Science. 1980;209(4458):768–76. doi:10.1126/science.6250214
   PubMed Web of Science ®Google Scholar
• Andrews P, Matin M, Bahrami A, Damjanov I, Gokhale P, et al. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. London (UK): Portland Press Limited; 2005.
   Google Scholar
• Yang H-M, Do H-J, Kim D-K, Park J-K, Chang W-K, Chung H-M, Choi S-Y, Kim J-H. Transcriptional regulation of human Oct4 by steroidogenic factor-1. J Cell Biochem. 2007;101(5):1198–209. doi:10.1002/jcb.21244
   PubMed Web of Science ®Google Scholar
• Jin B, Ernst J, Tiedemann RL, Xu H, Sureshchandra S, Kellis M, Dalton S, Liu C, Choi J-H, Robertson KD, et al. Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell Rep. 2012;2(5):1411–24.: doi:10.1016/j.celrep.2012.10.017
   PubMed Web of Science ®Google Scholar
• Tykwinska K, Lauster R, Knaus P, Rosowski M. Growth and differentiation factor 3 induces expression of genes related to differentiation in a model of cancer stem cells and protects them from retinoic acid-induced apoptosis. PloS One. 2013;8(8):e70612. doi:10.1371/journal.pone.0070612
   PubMed Web of Science ®Google Scholar
• Freberg CT, Dahl JA, Timoskainen S, Collas P. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol Biol Cell. 2007;18(5):1543–53. doi:10.1091/mbc.e07-01-0029
   PubMed Web of Science ®Google Scholar
• Hong SP, Wen J, Bang S, Park S, Song SY. CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells . Int J Cancer. 2009;125(10):2323–31. doi:10.1002/ijc.24573
   PubMed Web of Science ®Google Scholar
• Airley R. Cancer chemotherapy: basic science to the clinic. Hoboken (NJ): John Wiley & Sons; 2009.
   Google Scholar
• Phi LTH, Sari IN, Yang Y-G, Lee S-H, Jun N, Kim KS, Lee YK, Kwon HY. Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int. 2018;2018:5416923. doi:10.1155/2018/5416923
   PubMed Web of Science ®Google Scholar
• Oh J, Hlatky L, Jeong Y-S, Kim D. Therapeutic effectiveness of anticancer phytochemicals on cancer stem cells. Toxins. 2016;8(7):199. doi:10.3390/toxins8070199
   Web of Science ®Google Scholar
• Iqbal J, Abbasi BA, Mahmood T, Kanwal S, Ali B, Shah SA, Khalil AT. Plant-derived anticancer agents: A green anticancer approach. Asian Pacific Journal of Tropical Biomedicine. 2017;7(12):1129–50. doi:10.1016/j.apjtb.2017.10.016
   Web of Science ®Google Scholar
• Scarpa E-S, Ninfali P. Phytochemicals as innovative therapeutic tools against cancer stem cells. Int J Mol Sci. 2015;16(7):15727–42. doi:10.3390/ijms160715727
   PubMed Web of Science ®Google Scholar
• Pejin B, Kojic V, Bogdanovic G. An insight into the cytotoxic activity of phytol at in vitro conditions. Nat Prod Res. 2014;28(22):2053–6. doi:10.1080/14786419.2014.921686
   PubMed Web of Science ®Google Scholar
• Islam MT, Streck L, de Alencar MVOB, Cardoso Silva SW, da Conceição Machado K, da Conceição Machado K, Gomes Júnior AL, Paz MFCJ, da Mata AMOF, de Castro E Sousa JM, et al. Evaluation of toxic, cytotoxic and genotoxic effects of phytol and its nanoemulsion. Chemosphere. 2017;177:93–101.: doi:10.1016/j.chemosphere.2017.02.145
   PubMed Web of Science ®Google Scholar
• Sakthivel R, Malar DS, Devi KP. Phytol shows anti-angiogenic activity and induces apoptosis in A549 cells by depolarizing the mitochondrial membrane potential. Biomed Pharmacother. 2018;105:742–52. doi:10.1016/j.biopha.2018.06.035
   PubMed Web of Science ®Google Scholar
• Wei LS, Wendy W, Siong JYF, Syamsumir DF. Characterization of antimicrobial, antioxidant, anticancer properties and chemical composition of Sauropus androgynus stem extract. Acta Medica Lituanica. 2011;18(1):12–16. doi:10.6001/actamedica.v18i1.1808
   Google Scholar
• Roche J. The epithelial-to-mesenchymal transition in cancer. Basel (Switzerland): Multidisciplinary Digital Publishing Institute; 2018.
   Google Scholar
• Pearson GW. Control of invasion by epithelial-to-mesenchymal transition programs during metastasis. JCM. 2019;8(5):646. doi:10.3390/jcm8050646
   Google Scholar
• Moustakas A, de Herreros AG. Epithelial-mesenchymal transition in cancer. Mol Oncol. 2017;11(7):715–7. doi:10.1002/1878-0261.12094
   PubMed Web of Science ®Google Scholar
• Rizzino A. Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells . Wiley Interdiscip Rev Syst Biol Med. 2009;1(2):228–36. doi:10.1002/wsbm.12
   PubMed Web of Science ®Google Scholar
• Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. cell. 2005;122(6):947–56.: doi:10.1016/j.cell.2005.08.020
   PubMed Web of Science ®Google Scholar
• Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Oncol Rep. 2012;28(4):1301–8. doi:10.3892/or.2012.1951
   PubMed Web of Science ®Google Scholar
• Dean M. ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia. 2009;14(1):3–9. doi:10.1007/s10911-009-9109-9
   PubMed Web of Science ®Google Scholar
• Chen L-S, Wang A-X, Dong B, Pu K-F, Yuan L-H, Zhu Y-M. A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancer. Chin J Cancer. 2012;31(12):564–72. doi:10.5732/cjc.011.10444
   PubMedGoogle Scholar
• Wu C-P, Calcagno AM, Ambudkar SV. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr Mol Pharmacol. 2008;1(2):93–105. doi:10.2174/1874467210801020093
   PubMedGoogle Scholar
• Wu C, Alman BA. Side population cells in human cancers. Cancer Lett. 2008;268(1):1–9. doi:10.1016/j.canlet.2008.03.048
   PubMed Web of Science ®Google Scholar
• Vasiliou V, Pappa A, Petersen DR. Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem Biol Interact. 2000;129(1-2):1–19. doi:10.1016/s0009-2797(00)00211-8
   PubMed Web of Science ®Google Scholar
• Moreb JS. Aldehyde dehydrogenase as a marker for stem cells. Curr Stem Cell Res Ther. 2008;3(4):237–46. doi:10.2174/157488808786734006
   PubMed Web of Science ®Google Scholar
• Damjanov I, Horvat B, Gibas Z. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. Lab Invest. 1993;68(2):220–32.
   PubMed Web of Science ®Google Scholar
• Andrews PW. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol. 1984;103(2):285–93. doi:10.1016/0012-1606(84)90316-6
   PubMed Web of Science ®Google Scholar
• Massard C, Deutsch E, Soria J. Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol. 2006;17(11):1620–4. doi:10.1093/annonc/mdl074
   PubMed Web of Science ®Google Scholar
• Soltanian S, Matin MM. Cancer stem cells and cancer therapy. Tumour Biol. 2011;32(3):425–40. doi:10.1007/s13277-011-0155-8
   PubMed Web of Science ®Google Scholar
• Soltanian S, Dehghani H, Matin MM, Bahrami AR. Expression analysis of BORIS during pluripotent, differentiated, cancerous, and non-cancerous cell states. Acta Biochim Biophys Sin (Shanghai)). 2014;46(8):647–58. doi:10.1093/abbs/gmu045
   PubMed Web of Science ®Google Scholar
• Soltanian S, Dehghani H. BORIS: a key regulator of cancer stemness. Cancer Cell Int. 2018;18(1):154doi:10.1186/s12935-018-0650-8
   PubMedGoogle Scholar
• Stevanovic M. Modulation of SOX2 and SOX3 gene expression during differentiation of human neuronal precursor cell line NTERA2. Mol Biol Rep. 2003;30(2):127–32. doi:10.1023/a:1023961009869
   PubMed Web of Science ®Google Scholar
• Rassouli FB, Matin MM, Bahrami AR, Ghaffarzadegan K, Cheshomi H, Lari S, Memar B, Kan MS. Evaluating stem and cancerous biomarkers in CD15 + CD44+ KYSE30 cells. Tumour Biol. 2013;34(5):2909–20. doi:10.1007/s13277-013-0853-5
   PubMedGoogle Scholar
• Popovic J, Stanisavljevic D, Schwirtlich M, Klajn A, Marjanovic J, Stevanovic M. Expression analysis of SOX14 during retinoic acid induced neural differentiation of embryonal carcinoma cells and assessment of the effect of its ectopic expression on SOXB members in HeLa cells. PloS One. 2014;9(3):e91852doi:10.1371/journal.pone.0091852
   PubMed Web of Science ®Google Scholar
• Boer B, Kopp J, Mallanna S, Desler M, Chakravarthy H, Wilder PJ, Bernadt C, Rizzino A. Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Res. 2007;35(6):1773–86. doi:10.1093/nar/gkm059
   PubMed Web of Science ®Google Scholar
• Adachi K, Suemori H, Yasuda S, Nakatsuji N, Kawase E. Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells. 2010;15(5):455–70. doi:10.1111/j.1365-2443.2010.01400.x
   PubMed Web of Science ®Google Scholar
• Drakulic D, Krstic A, Stevanovic M. Establishment and initial characterization of SOX2-overexpressing NT2/D1 cell clones. Genet Mol Res. 2012;11(2):1385–400. doi:10.4238/2012.May.15.9
   PubMed Web of Science ®Google Scholar
• Kopp JL, Ormsbee BD, Desler M, Rizzino A. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells. 2008;26(4):903–11. doi:10.1634/stemcells.2007-0951
   PubMed Web of Science ®Google Scholar
• Episkopou V. SOX2 functions in adult neural stem cells. Trends Neurosci. 2005;28(5):219–21. doi:10.1016/j.tins.2005.03.003
   PubMed Web of Science ®Google Scholar
• Gasimli L, Stansfield HE, Nairn AV, Liu H, Paluh JL, Yang B, Dordick JS, Moremen KW, Linhardt RJ. Structural remodeling of proteoglycans upon retinoic acid-induced differentiation of NCCIT cells. Glycoconj J. 2013;30(5):497–510. doi:10.1007/s10719-012-9450-x
   PubMed Web of Science ®Google Scholar
• Herreros-Villanueva M, Er T-K, Bujanda L. Retinoic acid reduces stem cell-like features in pancreatic cancer cells. Pancreas. 2015;44(6):918–24. doi:10.1097/MPA.0000000000000373
   PubMed Web of Science ®Google Scholar
• Nguyen PH, Giraud J, Staedel C, Chambonnier L, Dubus P, Chevret E, Boeuf H, Gauthereau X, Rousseau B, Fevre M, et al. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth. Oncogene. 2016;35(43):5619–28.: doi:10.1038/onc.2016.87
   PubMed Web of Science ®Google Scholar
• Bouriez D, Giraud J, Gronnier C, Varon C. Efficiency of all-trans retinoic acid on gastric cancer: a narrative literature review. IJMS. 2018;19(11):3388. doi:10.3390/ijms19113388
   Google Scholar
• Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337(15):1021–8.: doi:10.1056/NEJM199710093371501
   PubMed Web of Science ®Google Scholar
• Florea A-M, Büsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel). 2011;3(1):1351–71. doi:10.3390/cancers3011351
   PubMedGoogle Scholar
• Park S, Sung J, Chung N. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2. Mol Cell Biochem. 2014;394(1-2):209–15. doi:10.1007/s11010-014-2096-1
   PubMed Web of Science ®Google Scholar
• Kim JB, Ko E, Han W, Shin I, Park SY, Noh D-Y. Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells. Planta Med. 2008;74(14):1693–700. doi:10.1055/s-0028-1088313
   PubMed Web of Science ®Google Scholar